Cutting Edge: Cure of Colitis by CD4+CD25+ Regulatory T Cells
Indexed incrossrefpubmed
Abstract
CD4(+)CD25(+) regulatory T cells have been shown to prevent T cell-mediated immune pathology; however, their ability to ameliorate established inflammation has not been tested. Using the CD4(+)CD45RB(high) T cell transfer model of inflammatory bowel disease, we show that CD4(+)CD25(+) but not CD4(+)CD25(-)CD45RB(low) T cells are able to cure intestinal inflammation. Transfer of CD4(+)CD25(+) T cells into mice with colitis led to resolution of the lamina propria infiltrate in the intestine and reappearance of normal intestinal architecture. CD4(+)CD25(+) T cells were found to proliferate in the mesenteric lymph nodes and inflamed colon. They were located between clusters of CD11c(+) cells and pathogenic T cells…
Citation impact
918
total citations
- FWCI
- 21.51
- Percentile
- 100%
- References
- 21
Citations per year
Authors
3Topics & keywords
Topics
Keywords
- IL-2 receptor
- Colitis
- Lamina propria
- Inflammation
- Mesenteric lymph nodes
- Inflammatory bowel disease
- Immunology
- CD11c
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.